The ARL6 Knockout A-549 Polyclonal Cells product is a pool of A-549 human lung adenocarcinoma epithelial cells that have been subjected to CRISPR/Cas9-mediated gene disruption of ARL6. Offered as polyclonal knockout cells, this population preserves genetic heterogeneity, making it a robust loss-of-function model for functional genomics studies. The knockout approach targets the ARL6 gene broadly, enabling investigation of its roles without the confounding influence of clonal selection. Researchers can employ these cells to deconvolve signaling networks in a readily transfectable adherent epithelial line.
The A-549 host cell line originates from a 58-year-old Caucasian male with lung adenocarcinoma; it is a widely employed model for lung epithelial biology and cancer research. These cells exhibit characteristic epithelial morphology and express markers typical of alveolar type II pneumocytes. Their well-documented growth properties and susceptibility to genetic manipulation make them a versatile platform for dissecting molecular mechanisms underlying tumorigenesis and ciliary function.
ARL6 (BBS3) encodes a small GTPase of the ARF family that orchestrates ciliary trafficking as a key regulator of the BBSome complex. Upon GTP binding, ARL6 is activated by guanine nucleotide exchange factors and modulated by GTPase-activating proteins; it then recruits the BBSome??comprising subunits BBS1, BBS2, BBS4, BBS5, BBS7, BBS8, and BBS9??to membranes. This interaction facilitates the ciliary entry of G protein-coupled receptors including SSTR3 and MCHR1, and propagates Sonic hedgehog signaling via Smoothened translocation. ARL6 functions within a network involving intraflagellar transport components (IFT20, IFT88), Rab8 GTPase, and the exocyst complex at the primary cilium transition zone.
In the A-549 lung adenocarcinoma background, disruption of ARL6 provides a means to explore the intersection between ciliary signaling and oncogenesis. While primary cilia can influence proliferation and migration, their status in A-549 cells allows direct assessment of ciliary protein contributions to epithelial malignancies. This knockout model is thus relevant to Bardet-Biedl syndrome type 3 pathophysiology and broader ciliopathy research, as well as to lung cancer studies where hedgehog and GPCR pathways are often deregulated.
Typical applications include immunofluorescence microscopy for cilium visualization, ciliary trafficking assays utilizing SSTR3-GFP, and western blotting for ARL6 loss validation. These cells are suitable for RT-qPCR profiling of hedgehog target gene expression, migration and invasion assays, and chemotherapeutic drug sensitivity testing. Transcriptomic analyses via RNA-seq can uncover ARL6-dependent gene networks. For detailed protocols or product support, please contact Ascent Research.
